INTERNATIONAL UROLOGY AND NEPHROLOGY, published by SPRINGER, stands as a premier journal in the fields of urology and nephrology, boasting a commendable impact factor as reflected in its Q2 category rankings in both domains as of 2023. Since its inception in 1970, the journal has dedicated itself to disseminating cutting-edge research and clinical advancements that significantly impact the practice and understanding of urology and nephrology. With a Scopus rank placing it in the upper percentiles—46th out of 120 in urology and 38th out of 81 in nephrology—it offers a vital platform for researchers, healthcare professionals, and students alike to engage with high-quality, peer-reviewed articles. Although it does not operate as an open access journal, the wealth of knowledge contained within its pages remains indispensable for those committed to advancing the medical fields of urology and nephrology. The journal is located in Dordrecht, Netherlands, emphasizing its commitment to global research collaboration.

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

RENAL FAILURE is a distinguished academic journal published by TAYLOR & FRANCIS LTD, focusing on pivotal research in the fields of nephrology, critical care, and intensive care medicine. With an impact factor reflecting its significant contribution to the medical community, this open access journal has been providing a platform for peer-reviewed articles since its inception, offering free visibility to cutting-edge research since 2016. Based in the United Kingdom, RENAL FAILURE is essential for professionals, researchers, and students who seek to stay informed about the latest advancements and clinical practices in renal care. The journal’s Scopus ranking places it among the top-tier publications in its category, boasting a Q2 ranking in critical care, general medicine, and nephrology, underscoring its impactfulness in the global research landscape. Catering to a wide audience, it spans literature from 1976 through 2024, making it a cornerstone resource for anyone dedicated to enhancing the understanding and treatment of renal diseases.

The Indian Journal of Nephrology is a premier Open Access publication dedicated to advancing the field of nephrology. Published by Wolters Kluwer Medknow Publications since 2007, this journal has become a vital resource for researchers, clinicians, and students alike, providing them with a platform to disseminate innovative research findings and clinical perspectives in kidney health. With an ISSN of 0971-4065 and E-ISSN of 1998-3662, the journal plays a significant role in the dissemination of knowledge in the nephrology community, especially in India. Despite its Q3 ranking in nephrology according to the 2023 Category Quartiles, the journal reaches a diverse audience through its extensive Open Access model, promoting visibility and accessibility for all contributors. The converged years from 2009 to 2024 reflect its ongoing commitment to publishing impactful and relevant research, thus reinforcing its importance as a reliable source for the evolution of nephrological studies.

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

The American Journal of Kidney Diseases, published by W B Saunders Co-Elsevier Inc, stands as a premier academic resource in the field of nephrology, with an impressive impact factor that highlights its significance in advancing kidney health research. Since its inception in 1981, this journal has consistently provided a platform for innovative studies and critical reviews that shape clinical practices and policies in kidney disease management, achieving a prestigious Q1 ranking within the nephrology category as of 2023. With an H-index reflective of its research dynamism and influence, the journal has become an essential read for professionals, researchers, and students keen on the latest scientific advancements. While the journal does not offer Open Access, it continues to maintain high standards for the quality and relevance of its published content, making it indispensable for those dedicated to understanding and combating kidney diseases. Its address is located in Philadelphia, PA, further solidifying its commitment to fostering knowledge in the United States and beyond.

The International Journal of Nephrology is a premier peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of nephrology through the dissemination of high-quality research. With an ISSN of 2090-214X and an E-ISSN of 2090-2158, this open-access journal has been providing a platform for scholarly articles since 2010, ensuring that both researchers and practitioners have immediate access to the latest findings in kidney health and disease. As of 2023, it holds a reputable Q2 rating in the nephrology category, ranking 36th out of 81 journals in Scopus, placing it in the 56th percentile. The journal aims to foster innovation and collaboration within the nephrology community by covering a broad scope of topics, including clinical and experimental research, innovative treatments, and public health initiatives related to kidney disorders. Situated in the United States, the International Journal of Nephrology is committed to enhancing understanding and improving outcomes in nephrology by bridging academia with clinical practice, making it an essential resource for academics, clinicians, and students alike.

Kidney International Supplements is a prestigious academic journal published by Elsevier Science Inc, specializing in the field of nephrology. With an impressive impact factor and ranked in the top percentile, it holds the esteemed position of Q1 in nephrology categories, reflecting its influential contribution to the academic community. Throughout its publication history from 2011 to 2022 and in the anticipated 2024 edition, the journal has provided a vital platform for disseminating high-quality research and insights, catering to professionals, researchers, and students dedicated to advancing kidney health. While it offers traditional access options, the journal is committed to promoting the highest standards of research integrity and innovation in nephrology. The journal plays an essential role in shaping the future of kidney disease treatment, levelling knowledge exchange across specialties, and fostering collaboration among experts in the field.